Menu Expand
Glycemic Monitoring - ECAB

Glycemic Monitoring - ECAB

Rangasamy V. Jayakumar

(2009)

Additional Information

Book Details

Abstract

Diabetes is a chronic disease that is reaching an epidemic proportion in many parts of the world. Despite the high incidence of diabetes, individuals diagnosed with the disorder are only 50%. The main challenge

of medical professionals in diagnosing and treating the diabetic patients is the lack of understanding of the disease, which usually leads to problems with treatment compliance and monitoring.

There is strong evidence to show that an effective intensive glycemic control reduces various microvascular and neuropathic complications of diabetes mellitus. The Diabetes Control and Complications Trial (DCCT) showed that the intensive glycemic control prevented diabetic complications in type 1 diabetic patients, and the HbA1c levels reduced by 1.5–2.0%. In the UKPDS study, a modest improvement in HbA1c (a difference of 0.9 %) in the intensively treated group than in the control group brought about a 25% reduction in microvascular complications and a 12% reduction in all diabetes related events. There are several methods with differing utilities and limitations existing for monitoring glycemic status in individuals.

Diabetes care in India leaves much to be desired and suggested, and there is a need for efforts to increase awareness of both the patients and the doctors for better treatment and monitoring.


Table of Contents

Section Title Page Action Price
Front Cover Front Cover
Front Matter ia
Copyright id
ECAB Clinical Update:Diabetology ie
Glycemic Monitoring if
About the Authors ig
Contents ii
ECAB Clinical Update InformationGLYCEMIC MONITORING i
Preface v
Relative Role of Various Parameters of Glycemic Monitoring in Indians 1a
ABSTRACT 1a
KEYWORDS 1a
Introduction 1a
Global Update 1a
Update in Indian Context 2
History of Diabetes in India 2
Burden of Diabetes in India 5
Personal clinical experience and management 5
Self-Monitoring of Blood Glucose 6
Aim 7
Advantages 7
Disadvantages 8
The Conditions Where SMBG is Not Possible 8
Indications 8
Conditions Where Strict Glycemic Control is Not Desirable 9
Frequency of Monitoring 9
In Type 1 DM Patients Who are on Intensive Therapy 10
During Pregnancy 10
In Type 2 Diabetes Mellitus 10
Conditions Requiring Frequent SMBG 10
The Method of Measurement of Blood Sugar by Blood Sugar Meter 10
Changes Made in the New Blood Sugar Meters 11
Blood Sugar Estimated by Blood Sugar Meter and Conventional Method (Laboratory Estimation) 11
Need of Blood Sugar Meter 12
SMBG by Blood Sugar Meter vs. Matched Strip 12
Factors Influencing the Results of SMBG by Blood Sugar Meter17-19 12
Noninvasive Methods of SMBG 12
Urine examination 13
Quantitative Analysis of Urine Glucose 16
Urine Ketone Examination 16
Tests for Urine Ketone Determination 16
Indications of Testing for Ketonuria 17
Serum 1,5-Anhydroglucitol 18
Blood Sugar Measurement 18
Measures of Long-Term Control 18
Glycation of Hemoglobin 19
Nomenclature 19
Glycated Hb in Nondiabetic Persons 20
Glycated Hb in Patients with Diabetes 20
Interpretation of Antecedent Glycemia from HbA1c 20
Glycated Hb and Chronic Complications in Diabetes 22
Assay Methods of Glycated Hemoglobin 22
Frequency of Testing HbA1c 23
Factors Affecting the Results of HbA1c 23
A1c Goals as per ADA Recommendation 2008 (Tables 3-6)34 23
Key Concepts in Setting Glycemic Goals 23
Fructosamine and Glycated Serum Proteins 24
Indianized Guidelines for Monitoring 25
Laboratory Assessment 25
Follow-up Evaluation35 26
Yearly Investigations 27
ICMR Guidelines 27
Conclusion 28
Case Studies Relative Role of Various Parameters of Glycemic Monitoring in Indians 33
Case study 1 33
Learning Lessons 34
Case study 2 34
Learning Lessons 35
Case study 3 35
Learning Lessons 36
Nonglycemic Parameters of Glycemic Monitoring in Diabetes 37a
ABSTRACT 37a
Socioeconomic Aspects of Glycemic Monitoring 52a
Summary 71
Other Books in This Series 72
DIABETES IN PREGNANCY 72
PREDIABETES 72
INFECTIONS IN DIABETES 73
DIETARY CONSIDERATIONS INDIABETES 75
CARDIOMETABOLIC RISK IN INDIA 75